Recent Finacing
Recent Raise
Gradientech develops QuickMIC, an ultra-rapid antibiotic susceptibility testing device providing susceptibility and dosage guidance, deployed in European hospitals and under 510(k) study with U.S./Canada commercialization via Hardy Diagnostics.
